Articles Tagged With:
-
New Insight into Anthracycline Cardiotoxicity
Cardiotoxicity occurs early on, and with prompt initiation of standard medical therapy for systolic heart failure, most patients can usually recover LV function.
-
Antiplatelet Therapy After TAVR: Where are the Data?
Dual antiplatelet therapy is associated with higher rates of bleeding compared with aspirin alone, but evidence supporting its efficacy post-transcatheter aortic valve replacement is sparse.
-
Is It Time to Purge Full-Strength Aspirin from the Outpatient Armamentarium?
There's further evidence of a lack of benefit to high-dose maintenance aspirin, along with a suggestion of harm.
-
IC requirements may be met, but do subjects comprehend what they sign?
There is a gap between what is required in the informed consent process for human subjects research, and the reality of how well the information is actually understood by participants. This was the focus of a March 2015 workshop convened by the Institute of Medicine’s Roundtable on Health Literacy.
-
Do physicians assume they know older patients’ wishes?
Clinicians often make inaccurate assumptions about older adults’ goals and cognitive capacity. This can lead to unwanted aggressive care or undertreatment.
-
COPD symptoms untreated prior to palliative medicine referral
Many physical and psychological symptoms were untreated prior to patients with COPD being seen in the outpatient palliative medicine clinic, according to a recent survey.
-
Burnout common among transplant surgeons
Forty percent of 218 transplant surgeons surveyed reported high levels of emotional exhaustion, according to a recent study conducted at the Henry Ford Transplant Institute in Detroit.
-
Caregivers’ choices not always aligned with patients’ wishes
Caregivers were more likely to pay to extend an end-stage cancer patient’s life than the patients themselves were, according to a recent study.
-
Clinicians: Patient, family factors obstacles to end-of-life discussions
Hospital-based clinicians see factors related to patients and family members as more important barriers to end-of-life discussions than clinician and system factors, according to the DECIDE study.
-
Risk of NSAID use in patients receiving antithrombotic therapy after myocardial infarction
Among patients receiving antithrombotic therapy after MI, the use of NSAIDs was associated with increased risk of bleeding and excess thrombotic events, even after short-term treatment.